Accession Number: | 0001209191-20-038963 |
Date: | 2020-06-23 |
Issuer: | ADVERUM BIOTECHNOLOGIES, INC. (ADVM) |
Original Submission Date: |
SCOPA JAMES PAUL
C/O ADVERUM BIOTECHNOLOGIES, INC.
800 SAGINAW DRIVE
REDWOOD CITY, CA 94063
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 25.64 | 2020-06-23 | deemed execution date | A | 30,000 (a) | 2030-06-22 | common stock 30,000 | $25.64 | 30,000 | direct |
ID | footnote |
---|---|
f1 | the shares subject to the option will vest on the earlier of june 23, 2021 or the 2021 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the reporting person's continued service with the issuer on the vesting date. |